Patents by Inventor Krista Lynne Kinneer

Krista Lynne Kinneer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795225
    Abstract: The present invention relates to binding molecules (e.g. antibodies) for the treatment of cancer, and related antibody-drug conjugates.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: October 24, 2023
    Assignee: MedImmune Limited
    Inventors: Krista Lynne Kinneer, Gareth Charles Davies, David Gareth Rees, Jennifer Louise Percival-Alwyn, John Edward Andrews, Jon Chesebrough
  • Publication number: 20230310636
    Abstract: Provided are methods of treating cancer in a subject, comprising administering to the subject: i) an antibody-drug conjugate (ADC), ii) a cytotoxic agent and iii) an additional agent, wherein the additional agent is a PARP1 inhibitor or an ATR inhibitor or a pharmaceutically acceptable salt thereof. The present disclosure further provides kits comprising i) an antibody-drug conjugate (ADC), ii) a cytotoxic agent and iii) an additional agent, wherein the additional agent is a PARP1 inhibitor or an ATR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 15, 2023
    Publication date: October 5, 2023
    Inventors: Krista Lynne KINNEER, Elisabetta LEO, Anne Frances TOSTO, Kimberly COOK, Jon CHESEBROUGH
  • Publication number: 20220098308
    Abstract: The present invention relates to binding molecules (e.g. antibodies) for the treatment of cancer, and related antibody-drug conjugates.
    Type: Application
    Filed: September 10, 2021
    Publication date: March 31, 2022
    Inventors: Krista Lynne Kinneer, Gareth Charles Davies, David Gareth Rees, Jennifer Louise Percival-Alwyn, John Edward Andrews, Jon Chesebrough